Armgard Büchel-Boekstegers, Markus Koster, Sven Lieberherr, Antonio Cozzio, Stefan Bilz
{"title":"[抗甲状腺药物治疗的罕见副作用]。","authors":"Armgard Büchel-Boekstegers, Markus Koster, Sven Lieberherr, Antonio Cozzio, Stefan Bilz","doi":"10.23785/PRAXIS.2024.09.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We report a case of Graves' disease in a patient who initially received carbimazole therapy, which was switched to propylthiouracil due to adverse effects. After 14 months of propylthiouracil therapy, the patient developed cutaneous ANCA-associated vasculitis. Prompt cessation of propylthiouracil and topical treatment led to complete resolution of the skin lesions.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 9","pages":"245-248"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[A rare side effect of antithyroid drug therapy].\",\"authors\":\"Armgard Büchel-Boekstegers, Markus Koster, Sven Lieberherr, Antonio Cozzio, Stefan Bilz\",\"doi\":\"10.23785/PRAXIS.2024.09.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>We report a case of Graves' disease in a patient who initially received carbimazole therapy, which was switched to propylthiouracil due to adverse effects. After 14 months of propylthiouracil therapy, the patient developed cutaneous ANCA-associated vasculitis. Prompt cessation of propylthiouracil and topical treatment led to complete resolution of the skin lesions.</p>\",\"PeriodicalId\":20494,\"journal\":{\"name\":\"Praxis\",\"volume\":\"113 9\",\"pages\":\"245-248\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Praxis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23785/PRAXIS.2024.09.006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Praxis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23785/PRAXIS.2024.09.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Introduction: We report a case of Graves' disease in a patient who initially received carbimazole therapy, which was switched to propylthiouracil due to adverse effects. After 14 months of propylthiouracil therapy, the patient developed cutaneous ANCA-associated vasculitis. Prompt cessation of propylthiouracil and topical treatment led to complete resolution of the skin lesions.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
